diagnosed with manometry, frequently found in asymptomatic patients and in patients with GERD, the clinical relevance of identifying IEM in order to phenotype and manage GERD remains unclear.
In this issue of Digestive Diseases and Sciences, Reddy and colleagues aim to characterize gastroesophageal reflux patterns among patients with IEM [5] . This retrospective cross-sectional study of esophageal manometry studies comparing up to 239 patients with IEM and 100 patients with normal esophageal motor function reports that patients with IEM have a higher number of reflux events as measured with impedance-pH monitoring (on or off acid suppression) and a greater acid exposure time as measured with pH monitoring performed off acid suppressive therapy. Furthermore, patients with IEM have a lower esophagogastric junction contractile integral, a surrogate measure of anti-reflux barrier integrity [6] . The authors further sub-group patients with IEM according to esophagogastric junction morphology type (I, II, and III), and note that patients with IEM and esophagogastric junction morphology type III (> 2 cm separation between the crural diaphragm and lower esophageal sphincter) have a higher body mass index, greater acid exposure, higher number of reflux events, and higher bolus exposure time.
The findings by Reddy and colleagues corroborate the notion that IEM is associated with GERD-associated pathologies such as increased reflux burden, a disrupted anti-reflux barrier, and obesity. An issue that remains unresolved in this observational study is the directionality of association. Does reduced esophageal contractility impair clearance of refluxate, increasing gastroesophageal reflux burden, or does chronic gastroesophageal reflux lead to esophageal injury and dysfunctional esophageal peristalsis? Regardless of the underlying pathophysiology, esophageal contractility seems to be a physiologically relevant component of GERD.
As the authors mention, the clinical significance of IEM in GERD is unknown. Thus, inclusion of patient-reported outcome instruments such as the GerdQ and the Brief Esophageal Dysphagia Questionnaire to measure the burden of symptoms in patients with IEM is a clear strength of the study design. Nevertheless, the authors do not identify any major differences in symptom burden in patients with IEM compared to those with normal esophageal motor function, possibly since the study may have been underpowered to detect meaningful differences. Moreover, symptom perception is multi-modal and influenced by unmeasured factors such as esophageal hypersensitivity and hypervigilance [7] . Therefore, this negative finding provokes the question: do patients with GERD require different management on the basis of esophageal motor function?
This work also heralds a growing challenge with regards to design of studies aiming to characterize phenotypes of GERD, and explore potential causal mechanisms. Since this study compared a sample of patients undergoing routine manometry with IEM to a random sample of individuals without IEM, it is not well suited to explore the relative prevalence of IEM among patients with a symptom complex of interest (in this case GERD), and the correlation or interaction of the key predictors of interest (presence vs. absence of IEM) with other parameters that could contribute to the symptom complex. Future studies should consider more rigorous observational designs, such as case-control and longitudinal cohort studies. For example, a case-control study could identify a study base of patients undergoing manometry, select a random sample of cases with the phenotype of interest (GERD on reflux monitoring) and a sample of controls without the phenotype, and be in a stronger position to understand the independent association between a key predictor such as IEM and case status. Further, this proposed study design could consider potential interactions and correlations between IEM and other factors and GERD risk, as well as examine its prevalence relative to other physiologic parameters and attributable risk.
Regardless of the physiologic or clinical relevance of IEM in GERD, and pending more rigorous studies, wellestablished management strategies used to treat IEM are not available. Reddy and colleagues suggest that the increased reflux events in patients with IEM may reflect an increased burden of transient lower esophageal sphincter relaxations in IEM. Therefore, inhibition of transient lower esophageal sphincter relaxations with GABA agonists is a potentially effective treatment strategy in patients with GERD and IEM. Accordingly, future work assessing the frequency of transient lower esophageal sphincter relaxations in GERD with IEM will be of interest. At present, since we speculate that the increased reflux events in IEM are related to a hypotensive lower esophageal sphincter and impaired anti-reflux integrity, adjusting for covariates in this statistical model may have been able to identify these interactions. Another shortcoming of the statistical model is the categorical nature of the primary outcome, which is dichotomized as normal esophageal motor function or IEM. For instance, the defined outcome categorizes a patient with 0% or 40% of weak swallows as normal, and a patient with 50% or 90% weak swallows as IEM even though all four represent different points on the spectrum of esophageal vigor, and those with 40% or 50% weak swallows are more similar than distinct.
Although the clinical utility of IEM in phenotyping patients with GERD is not clear, esophageal vigor and peristaltic reserve are relevant in terms of outcomes following anti-reflux surgery. Poor esophageal peristaltic reserve has been associated with late postoperative dysphagia and therefore may limit a patient's candidacy or require a tailored anti-reflux procedure [8] [9] [10] . Thus, characterizing esophageal motor function in GERD is an important component in the preoperative evaluation of foregut altering procedures.
In summary, Reddy and colleagues characterize patterns of reflux burden among patients with IEM, building on the existing literature in order to highlight the interrelation between esophageal hypomotility and gastroesophageal reflux burden. Moreover, this study highlights important gaps in knowledge as the field shifts toward phenotypeguided management for GERD and the need for more rigorous study designs in order to understand the relationship of measurable esophageal physiologic parameters and GERD. In order to translate the compelling physiologic findings from this study to the clinical setting, adequately powered outcomes studies need to examine treatment strategies according to GERD phenotype, taking into account a measure of esophageal contractility. Implicit to this is, further, the need for therapies that will effectively address esophageal contractility. This work underscores the clinical relevance of esophageal contractility in phenotyping and personalizing GERD management.
